Literature DB >> 25202109

Postoperative peripheral absolute blood lymphocyte-to-monocyte ratio predicts therapeutic outcome after pancreatic resection in patients with pancreatic adenocarcinoma.

Yuki Fujiwara1, Takeyuki Misawa2, Hiroaki Shiba2, Yoshihiro Shirai2, Ryota Iwase2, Koichiro Haruki2, Kenei Furukawa2, Yasuro Futagawa2, Katsuhiko Yanaga2.   

Abstract

AIM: The aim of this study was to evaluate the significance of postoperative peripheral absolute blood lymphocyte-to-monocyte (ALC/AMC) ratio in pancreatic resections for pancreatic carcinoma. PATIENTS AND METHODS: One hundred eleven patients who underwent pancreatic resection for pancreatic carcinoma were included in this study. We retrospectively examined perioperative findings as predictors of therapeutic outcome and the relation between postoperative ALC/AMC ratio and recurrence rate as well as overall survival of the patients with pancreatic carcinoma.
RESULTS: In univariate analysis, advanced tumor-node-metastasis (TNM) classification (p=0.0002), intraoperative flesh-frozen plasma (FFP) transfusion (p=0.0395), increased in preoperative serum carbohydrate antigen 19-9 (CA19-9) (p=0.0051) and lower postoperative ALC/AMC ratio (p=0.0007) were positively associated with poor disease-free survival. Advanced TNM classification (p=0.0008), intraoperative FFP transfusion (p=0.0343), elevated postoperative serum C-reactive protein (CRP) (p=0.0165) and lower postoperative ALC/AMC ratio (p=0.0029), as well as decreased preoperative lymphocyte counts (p=0.0248) were positively associated with poor overall survival. In multivariate analysis, advanced TNM classification (p=0.007), intraoperative FFP transfusion (p=0.0197), increase in preoperative serum CA19-9 (p=0.0075) and lower postoperative ALC/AMC ratio (p=0.0051) were independent factors for poor disease-free survival. Advanced TNM classification (p=0.0083), lower postoperative ALC/AMC ratio (p=0.0070) and elevated postoperative serum CRP (p=0.0094) were independent factors for poor overall survival.
CONCLUSION: Lower postoperative peripheral ALC/AMC ratio may have a negative impact on recurrence and overall survival after pancreatic resection for pancreatic carcinoma. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Lymphocyte-to-monocyte ratio; pancreatic adenocarcinoma; pancreatic resection; prognosis

Mesh:

Year:  2014        PMID: 25202109

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

1.  Local and systemic immunity predict survival in patients with pulmonary sarcomatoid carcinoma.

Authors:  Erin Schenk; Jennifer Boland; Aaron Mansfield; Marie Christine Aubry; Allan Dietz
Journal:  Med Oncol       Date:  2017-07-15       Impact factor: 3.064

2.  Does lymphocyte-to-monocyte ratio before, during, or after definitive chemoradiation for locally advanced pancreatic cancer predict for clinical outcomes?

Authors:  Irene Giacomelli; Daniele Scartoni; Homan Mohammadi; William F Regine; Michael D Chuong
Journal:  J Gastrointest Oncol       Date:  2017-08

3.  Evaluation of Early Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma Receiving Gemcitabine Together With Nab-paclitaxel.

Authors:  Wataru Izumo; Ryota Higuchi; Toru Furukawa; Takehisa Yazawa; Shuichiro Uemura; Yutaro Matsunaga; Masahiro Shiihara; Masakazu Yamamoto
Journal:  Cancer Diagn Progn       Date:  2021-11-03

4.  A Low Lymphocyte-to-Monocyte Ratio Predicts Unfavorable Prognosis in Pathological T3N0 Rectal Cancer Patients Following Total Mesorectal Excision.

Authors:  Wei-Wei Xiao; Lu-Ning Zhang; Kai-Yun You; Rong Huang; Xin Yu; Pei-Rong Ding; Yuan-Hong Gao
Journal:  J Cancer       Date:  2015-05-23       Impact factor: 4.207

5.  Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer.

Authors:  M Mego; H Gao; E N Cohen; S Anfossi; A Giordano; T Sanda; T M Fouad; U De Giorgi; M Giuliano; W A Woodward; R H Alvarez; V Valero; N T Ueno; G N Hortobagyi; M Cristofanilli; J M Reuben
Journal:  J Cancer       Date:  2016-06-03       Impact factor: 4.207

6.  Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinoma.

Authors:  Si-Wei Li; Wenxin Yuan; Bo Zhao; Zhuo-Kai He; Xiang Guo; Wei-Xiong Xia; Li-Hua Xu
Journal:  Cancer Cell Int       Date:  2016-07-04       Impact factor: 5.722

7.  Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study.

Authors:  Christelle d'Engremont; Dewi Vernerey; Anne-Laure Pointet; Gaël Simone; Francine Fein; Bruno Heyd; Stéphane Koch; Lucine Vuitton; Stefano Kim; Marine Jary; Najib Lamfichek; Celia Turco; Zaher Lakkis; Anne Berger; Franck Bonnetain; Julien Taieb; Philippe Bachellier; Christophe Borg
Journal:  BMC Cancer       Date:  2016-10-26       Impact factor: 4.430

8.  Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma.

Authors:  Gurshawn Singh; Ammar Nassri; David Kim; Hong Zhu; Zeeshan Ramzan
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-02-06

Review 9.  Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysis.

Authors:  Wendi Li; Lianyuan Tao; Lingfu Zhang; Dianrong Xiu
Journal:  Onco Targets Ther       Date:  2017-07-11       Impact factor: 4.147

10.  Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma.

Authors:  Guang-Jun Li; Hong-Wei Xu; Juan-Juan Ji; Fang Yang; Bao-Qin Gao
Journal:  Onco Targets Ther       Date:  2016-03-01       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.